Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 118

    1.

    The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.

    Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB.

    Diabetes. 2004 Apr;53(4):1068-73.PMID: 15047623 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study.

    Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, Simonsick EM, Colbert LH, Kritchevsky SB.

    Arterioscler Thromb Vasc Biol. 2003 Aug 1;23(8):1444-8. Epub 2003 Jun 5.PMID: 12791672 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome.

    Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr.

    JAMA. 2008 May 21;299(19):2287-93.PMID: 18492970 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?

    Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB.

    J Am Coll Cardiol. 2006 Sep 5;48(5):973-9. Epub 2006 Aug 17.PMID: 16949489 [PubMed - indexed for MEDLINE]Related articles

    5.

    NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.

    Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP).

    Diabetes. 2003 May;52(5):1210-4.PMID: 12716754 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Circulating oxidized LDL, measured with FOH1a/DLH3 antibody, is associated with metabolic syndrome and the coronary heart disease risk score in healthy Japanese.

    Ueba T, Nomura S, Nishikawa T, Kajiwara M, Yamashita K.

    Atherosclerosis. 2009 Mar;203(1):243-8. Epub 2008 Jun 3.PMID: 18635189 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?]

    Onat A, Yazici M, Hergenç G, Doğan Y, Karabulut A, Sari I, Türkmen S, Can G, Sansoy V.

    Anadolu Kardiyol Derg. 2005 Dec;5(4):271-7. Turkish. PMID: 16330391 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus.

    El Magadmi M, Ahmad Y, Turkie W, Yates AP, Sheikh N, Bernstein RM, Durrington PN, Laing I, Bruce IN.

    J Rheumatol. 2006 Jan;33(1):50-6.PMID: 16395749 [PubMed - indexed for MEDLINE]Related articles

    9.

    Oxidized LDL and coronary heart disease.

    Holvoet P.

    Acta Cardiol. 2004 Oct;59(5):479-84. Review.PMID: 15529550 [PubMed - indexed for MEDLINE]Related articles

    10.

    Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients.

    Girona J, Manzanares JM, Marimón F, Cabré A, Heras M, Guardiola M, Ribalta J, Masana L.

    Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):380-7. Epub 2007 Sep 29.PMID: 17904830 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined effect of the metabolic syndrome and hostility on the incidence of myocardial infarction (the Normative Aging Study).

    Todaro JF, Con A, Niaura R, Spiro A 3rd, Ward KD, Roytberg A.

    Am J Cardiol. 2005 Jul 15;96(2):221-6.PMID: 16018847 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

    Holvoet P.

    Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.PMID: 18669160 [PubMed - indexed for MEDLINE]Related articles

    13.

    Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome.

    Sjogren P, Basu S, Rosell M, Silveira A, de Faire U, Vessby B, Hamsten A, Hellenius ML, Fisher RM.

    Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2580-6. Epub 2005 Oct 13.PMID: 16224051 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.

    Bianchi C, Penno G, Malloggi L, Barontini R, Corfini M, Giovannitti MG, Di Cianni G, Del Prato S, Miccoli R.

    Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):31-8. Epub 2007 Apr 8.PMID: 17420118 [PubMed - indexed for MEDLINE]Related articles

    15.

    Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.

    Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W.

    Circulation. 2005 Aug 2;112(5):651-7. Epub 2005 Jul 25.PMID: 16043640 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA).

    Holvoet P, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR; Multi-Ethnic Study of Atherosclerosis.

    Atherosclerosis. 2007 Sep;194(1):245-52. Epub 2006 Sep 18.PMID: 16982059 [PubMed - indexed for MEDLINE]Related articles

    17.

    Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition study.

    Vogelzangs N, Beekman AT, Kritchevsky SB, Newman AB, Pahor M, Yaffe K, Rubin SM, Harris TB, Satterfield S, Simonsick EM, Penninx BW.

    J Gerontol A Biol Sci Med Sci. 2007 May;62(5):563-9.PMID: 17522363 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome.

    Cohn T, Prud'homme D, Streiner D, Kameh H, Remington G.

    Can J Psychiatry. 2004 Nov;49(11):753-60.PMID: 15633853 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

    Correll CU, Frederickson AM, Kane JM, Manu P.

    J Clin Psychiatry. 2006 Apr;67(4):575-83.PMID: 16669722 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs.

    Savage PD, Banzer JA, Balady GJ, Ades PA.

    Am Heart J. 2005 Apr;149(4):627-31.PMID: 15990744 [PubMed - indexed for MEDLINE]Related articles